
Zalika Pharmaceuticals Private Limited
About Zalika Pharmaceuticals Private Limited
Data last updated:
Zalika Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74995PN2018PTC176402. Its GSTIN is 27AABCZ2098P1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ameya Anant Budukh and Sameer Sidhram Kolhe.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 87 Vishal Industrial Estate Opp Ceat Tyres, Village Road Nahur Bhandup West Mumbai, Maharashtra, India – 400078.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zalika Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address87 Vishal Industrial Estate Opp Ceat Tyres, Village Road Nahur Bhandup West Mumbai, Maharashtra, India – 400078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zalika Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zalika Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Zalika Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zalika Pharmaceuticals Private Limited
Zalika Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ameya Anant Budukh Also directs: Maypharm Healthcare Private Limited, Maypharm Lifesciences Private Limited, THLC Consumer Products Private Limited and 2 more | Director | 03 May 2018 | 8 Years 6 Months | Current |
| Sameer Sidhram Kolhe | Director | 03 May 2018 | 8 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Zalika Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zalika Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zalika Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ2098P1ZJ | Maharashtra | Active | 13 Oct 2018 |
To see the full GST registrations and return filing status of Zalika Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zalika Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Daniela Lifschitz Tabak ceased to be Director on 23 Jul 2019.
Frequently asked questions
Zalika Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 May 2018 (8+ years old) and is registered under CIN U74995PN2018PTC176402.
Zalika Pharmaceuticals has 2 current directors:
- Ameya Anant Budukh - Director
- Sameer Sidhram Kolhe - Director
The latest financial statements of Zalika Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zalika Pharmaceuticals is 27AABCZ2098P1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zalika Pharmaceuticals is U74995PN2018PTC176402. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zalika Pharmaceuticals was incorporated on 03 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Daniela Lifschitz Tabak ceased to be Director on 23 Jul 2019. David Zylbergeld Neto ceased to be Director on 23 Jul 2019. Ameya Anant Budukh was appointed as Director on 03 May 2018. Zalika Pharmaceuticals has 4 board changes on record in total.
The registered office of Zalika Pharmaceuticals is at 87 Vishal Industrial Estate Opp Ceat Tyres, Village Road Nahur Bhandup West Mumbai, Maharashtra, India – 400078.
Zalika Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Zalika Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.

